Articles dans des revues avec comité de lecture (110)
  1. 92. Schmitz-Hübsch, T., Coudert, M., Bauer, P., Giunti, P., Globas, C., Baliko, L., Filla, A., Mariotti, C., Rakowicz, M., Charles, P., Ribai, P., Szymanski, S., Infante, J., van de Warrenburg, B. P., Dürr, A., Timmann, D., Boesch, S., Fancellu, R., Rola, R., Depondt, C., Schöls, L., Zdienicka, E., Kang, J.-S., Döhlinger, S., Kremer, B., Stephenson, D. A., Melegh, B., Pandolfo, M., di Donato, S., du Montcel, S. T., & Klockgether, T. (2008). Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology, 71(13), 982-989. doi:10.1212/01.wnl.0000325057.33666.72
  2. 93. Schmitz-Hübsch, T., Giunti, P., Stephenson, D. A., Globas, C., Baliko, L., Saccà, F., Mariotti, C., Rakowicz, M., Szymanski, S., Infante, J., van de Warrenburg, B. P., Timmann, D., Fancellu, R., Rola, R., Depondt, C., Schöls, L., Zdzienicka, E., Kang, J.-S., Döhlinger, S., Kremer, B., Melegh, B., Filla, A., & Klockgether, T. (2008). SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology, 71(7), 486-492. doi:10.1212/01.wnl.0000324863.76290.19
  3. 94. Depondt, C. (2008). Pharmacogenetics in epilepsy treatment: Sense or nonsense? Personalized medicine, 5(2), 123-131. doi:10.2217/17410541.5.2.123
  4. 95. Cavalleri, G. L., Weale, M. E., Shianna, K. V., Singh, R., Lynch, J. M., Grinton, B., Szoeke, C., Murphy, K., Kinirons, P., O'Rourke, D., Ge, D., Depondt, C., Claeys, K. G., Pandolfo, M., Gumbs, C., Walley, N., McNamara, J., Mulley, J. C., Linney, K. N., Sheffield, L. J., Radtke, R. A., Tate, S. K., Chissoe, S. L., Gibson, R. A., Hosford, D., Stanton, A., Graves, T. D., Hanna, M. G., Eriksson, K., Kantanen, A.-M., Kalviainen, R., O'Brien, T. J., Sanders, J., Duncan, J. S., Scheffer, I. E., Berkovic, S. F., Wood, N. W., Doherty, C. P., Delanty, N., Sisodiya, S. M., & Goldstein, D. B. (2007). Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet neurology, 6(11), 970-980. doi:10.1016/S1474-4422(07)70247-8
  5. 96. Cavalleri, G. L., Walley, N., Soranzo, N., Mulley, J. C., Doherty, C. P., Kapoor, A., Depondt, C., Lynch, J. M., Scheffer, I. E., Heils, A., Gehrmann, A., Kinirons, P., Gandhi, S., Satishchandra, P., Wood, N. W., Anand, A., Sander, T., Berkovic, S. F., Delanty, N., Goldstein, D. B., & Sisodiya, S. M. (2007). A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy. Epilepsia, 48(4), 706-712. doi:10.1111/j.1528-1167.2007.00977.x
  6. 97. Depondt, C. (2006). Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model. Acta neurologica belgica, 106(4), 157-167.
  7. 98. Tate, S. K., Singh, R., Hung, C.-C., Tai, J. J., Depondt, C., Cavalleri, G. L., Sisodiya, S. M., Goldstein, D. B., & Liou, H.-H. (2006). A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose. Pharmacogenetics and genomics, 16(10), 721-726. doi:10.1097/01.fpc.0000230114.41828.73
  8. 99. Ossemann, M., Bruls, E., de Borchgrave d'Alténa, V., De Cock, C., Delcourt, C., Delvaux, V., Depondt, C., De Tourtchaninoff, M., Grisar, T., Legros, B., Liénard, F., Lievens, I., Sadzot, B., van Rijckevorsel, K., & Groupe de travail des Centres francophones de référence de I'epilepsie réfractaire, (2006). Guidelines for the management of epilepsy in the elderly. Acta neurologica belgica, 106(3), 111-116.
  9. 100. Depondt, C., & Shorvon, S. (2006). Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications. Pharmacogenomics, 7(5), 731-745. doi:10.2217/14622416.7.5.731
  10. 101. Schmitz-Hübsch, T., du Montcel, S. T., Baliko, L., Berciano, J., Boesch, S., Depondt, C., Giunti, P., Globas, C., Infante, J., Kang, J.-S., Kremer, B., Mariotti, C., Melegh, B., Pandolfo, M., Rakowicz, M., Ribai, P., Rola, R., Schöls, L., Szymanski, S., van de Warrenburg, B. P., Dürr, A., Klockgether, T., & Fancellu, R. (2006). Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology, 66(11), 1717-1720. doi:10.1212/01.wnl.0000219042.60538.92
  11. 102. Depondt, C. (2006). The potential of pharmacogenetics in the treatment of epilepsy. European journal of paediatric neurology, 10(2), 57-65. doi:10.1016/j.ejpn.2005.11.009
  12. 103. Depondt, C., Yuen, A. W. C., Bell, G., Mitchell, T., Koepp, M. J., Duncan, J. S., & Sander, J. W. (2006). The long term retention of levetiracetam in a large cohort of patients with epilepsy. Journal of neurology, neurosurgery and psychiatry, 77(1), 101-103. doi:10.1136/jnnp.2005.064626
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>